Wealth Advisors of Iowa’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,127
Closed -$314K 65
2022
Q4
$314K Buy
6,127
+302
+5% +$14.5K 0.26% 46
2022
Q3
$255K Sell
5,825
-2,871
-33% -$140K 0.24% 43
2022
Q2
$456K Buy
+8,696
New +$443K 0.08% 58
2022
Q1
Sell
-9,900
Closed -$585K 70
2021
Q4
$585K Sell
9,900
-1,344
-12% -$66.6K 0.32% 28
2021
Q3
$484K Sell
11,244
-570
-5% -$25.3K 0.26% 32
2021
Q2
$463K Sell
11,814
-200
-2% -$7.78K 0.24% 32
2021
Q1
$435K Buy
+12,014
New +$427K 0.24% 30

Other funds holding PFE

Wealth Advisors of Iowa's PFE Position: Q1 2023 in Review

Wealth Advisors of Iowa sold out of Pfizer (PFE) in Q1 2023, closing a stake of 6,127 shares — an estimated $314K sold.

Wealth Advisors of Iowa first reported a position in PFE in Q1 2021 and held it in 7 quarters. The position peaked at $585K in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Wealth Advisors of Iowa reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Wealth Advisors of Iowa sold 6,127 Pfizer shares in Q1 2023, an estimated $314K.
  • Wealth Advisors of Iowa first reported a position in Pfizer in Q1 2021 and held it in 7 quarters.
  • Wealth Advisors of Iowa's Pfizer position peaked at $585K in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Wealth Advisors of Iowa's 13F filing for Q1 2023, filed 9 May 2023.